PROTEST
Hibsago Bepirovirsen Approved in Canada as the First and Only Finite Therapy Indicated to Achieve Functional Cure of Chronic Hepatitis B
PROTEST signal, reported in CA, from thesudburystar.com, with neutral sentiment. Locations: Canada, United States, Japan.
What This Signal Means
This page turns one GDELT event record into a readable WorldEchoNews signal. The signal is categorized as PROTEST for CA, with neutral sentiment and a tone score of -2.46. 4 distinct reporting sources linked to this event.
Tone Reading
The tone score is used as a quick language-intensity indicator. Scores below -5 are treated as negative, scores above 5 are treated as positive, and values between -5 and 5 are treated as neutral. This signal has a moderate neutral reading.
Reporting Sources
These source names were attached to matching GDELT mentions for this event.
cbc.ca
northernnews.ca
recorder.ca
thesudburystar.com
People: Jennifer Nebesky, Michelle Horn
Organizations: Public Health Agency Of Canada, Ionis Pharmaceuticals, Health Canada Priority, United States
Locations: Canada, United States, Japan
Activity in CA (last 24 hours)
286signals recorded
-1.5average tone
50strongly negative
Counted across every source WorldEchoNews processed in the window, not just this story.